Can we distinct short- and long-term cellular immunity in order to improve vaccination strategies? In this position at RIVM you will contribute to public health by generating and analyzing single-cell datasets for exploring why longevity of cellular immunity induced by different vaccines and pathogens differs. You will have access to unique clinical cohorts, cutting-edge flow cytometry and sequencing technologies, and dedicated bioinformatic support. This two-year post offers a collaborative, research-focused environment where your daily laboratory work shapes meaningful scientific insights.
Your responsibilities
Understanding the mechanisms behind why cell-mediated immunity lasts for decades after certain infections or vaccines, while fading quickly after others, is crucial for designing next-generation public health strategies. In this two-year position you address this question by mapping antigen-specific B and T cell responses at single-cell resolution.
Your primary focus is the hands-on generation and analysis of single-cell datasets from clinical cohorts. Working within a dedicated project team, you profile cellular immune responses triggered by various pathogens and vaccines to evaluate both the depth and longevity of protection. You work closely alongside an experienced bioinformatician to integrate, interpret, and translate complex laboratory data into immunological insights.
Your key tasks include:
- Designing and performing laboratory experiments for generating flow cytometry and single-cell omics datasets from human clinical studies on cellular responses following infection or vaccination.
- Analyzing and visualizing flow cytometry and single-cell datasets.
- Coordinating and safeguarding the timing and quality of completing project deliverables.
- Publishing research results in peer-reviewed journals to communicate findings.
- Presenting research outcomes at meetings and conferences.
By generating these high-dimensional single-cell datasets, you help uncover the biological determinants of durable immunity, offering evidence that can refine future vaccination frameworks. Beyond the daily laboratory and data work, you will have access to advanced sequencing technologies and patient samples, with space to strengthen your analytical approach and share findings through peer-reviewed scientific publications.
About the department
The Centre for Immunology of Infectious Diseases and Vaccines (IIV) at the Dutch National Institute for Public Health and the Environment (RIVM) conducts high-impact research on how the immune system responds to vaccines and infections. We focus on protecting vulnerable groups such as infants and older adults. Our Immune Mechanisms – Correlates of Protection (IMC) department identifies biomarkers of protective immunity through clinical studies, contributing to vaccine effectiveness and policy decisions.
For this project you will work closely with a principal investigator, a bioinformatician, and a technician. You will regularly collaborate with the project team to share progress and exchange ideas in an open, supportive environment. As a team, we tackle challenges together and celebrate our milestones with a slice of cake. You will also participate in IMC department and IIV centre meetings, giving you the opportunity to discuss research with fellow scientists. Beyond that, you can connect with colleagues informally during centre lunches, drinks, and social activities. We offer a flexible working environment through our hybrid work policy. We gather on-site two fixed days a week to connect as a team and with the broader centre, while offering the flexibility to work remotely when your tasks allow.
How to apply and more information
Are you excited to join our team and contribute to essential public health research? Apply now and send your application to Dr. Jelle de Wit, head of the IMC department.
For more information, feel free to contact Jelle de Wit (+3188 689 3109) or René Raeven (+316 3198 4662). We'd love to hear from you!
The interviews for this position will be held on Wednesday November 11th and Friday November 13th.